|
Originally published In Press as doi:10.1074/jbc.M003822200 on September 7, 2000
J. Biol. Chem., Vol. 275, Issue 51, 39886-39893, December 22, 2000
Non-coordinate Regulation of Endogenous Epithelial Sodium Channel
(ENaC) Subunit Expression at the Apical Membrane of A6 Cells in
Response to Various Transporting Conditions*
Ora A.
Weisz,
Jun-Min
Wang,
Robert S.
Edinger, and
John P.
Johnson
From the Laboratory of Epithelial Cell Biology, Renal-Electrolyte
Division, University of Pittsburgh,
Pittsburgh, Pennsylvania 15261
Received for publication, May 4, 2000, and in revised form, September 6, 2000
 |
ABSTRACT |
In many epithelial tissues in the body
(e.g. kidney distal nephron, colon, airways) the rate of
Na+ reabsorption is governed by the activity of the
epithelial Na+ channel (ENaC). ENaC activity in turn is
regulated by a number of factors including hormones, physiological
conditions, and other ion channels. To begin to understand the
mechanisms by which ENaC is regulated, we have examined the trafficking
and turnover of ENaC subunits in A6 cells, a polarized, hormonally
responsive Xenopus kidney cell line. As previously observed
by others, the half-life of newly synthesized ENaC subunits was
universally short (~2 h). However, the half-lives of - and
-ENaC subunits that reached the apical cell surface were
considerably longer (t1/2 > 24 h), whereas
intriguingly, the half-life of cell surface -ENaC was only
approximately 6 h. We then examined the effects of various modulators of sodium transport on cell surface levels of individual ENaC subunits. Up-regulation of ENaC-mediated sodium conductance by
overnight treatment with aldosterone or by short term incubation with
vasopressin dramatically increased cell surface levels of -ENaC
without affecting - or -ENaC levels. Conversely, treatment with
brefeldin A selectively decreased the amount of -ENaC at the apical
membrane. Short term treatment with aldosterone or insulin had no
effect on cell surface amounts of any subunits. Subcellular
fractionation revealed a selective loss of -ENaC from early
endosomal pools in response to vasopressin. Our data suggest the
possibility that trafficking and turnover of individual ENaC subunits
at the apical membrane of A6 cells is non-coordinately regulated. The
selective trafficking of -ENaC may provide a mechanism for
regulating sodium conductance in response to physiological stimuli.
 |
INTRODUCTION |
The kidney regulates extracellular fluid volume in the body
through modulation of Na+ reabsorption along the nephron.
The ultimate regulation of Na+ reabsorption occurs at the
apical surface of collecting ducts and is mediated by the epithelial
sodium channel (ENaC).1 ENaC
is also located at the apical membrane of other epithelial tissues
throughout the body, including colon, sweat glands, and airway (1).
Abnormalities of function of this channel, linked to inherited
alterations in channel structure, have been shown to be important in
several human diseases, including the hypertension seen in patients
with Liddle's Syndrome (2) and the salt-wasting seen with some
variants of psuedohypoaldosteronism (3). In addition, apparent
overactivity of this channel, seen in the presence of common mutations
of the cystic fibrosis transmembrane conductance regulator, has been
linked to the pathogenesis of airway disease in cystic fibrosis (4).
However, little is known about how ENaC activity is regulated under
different physiological states.
The primary structure of ENaC was elucidated through expression cloning
(5) and revealed that the channel is formed by three homologous
subunits, , , and . When these three subunits are expressed
together in Xenopus oocytes, they produce a channel with the
typical biophysical and pharmacologic properties of the native channel:
low conductance, high Na+/K+ selectivity, and
sensitivity to amiloride in the submicromolar range (1, 5, 6). However,
the open probability of this channel in oocytes is much higher than in
most tissues, suggesting that this expression system lacks
physiologically important regulation machinery for ENaC (7). Moreover,
the expression, activity, stoichiometry, and trafficking of ENaC in
various tissues appears to be differentially regulated and complex.
Thus, a complete understanding of ENaC trafficking and regulation
requires examination of these processes in cells from tissues that
express the channel endogenously.
We have investigated the trafficking and turnover of individual ENaC
subunits in the hormonally responsive Xenopus kidney cell
line A6. Interestingly, we find that Xenopus ENaC subunits (xENaCs) at the apical cell surface have different half-lives and that
xENaC subunits traffic to the cell surface in a non-coordinate fashion
in response to a subset of transport-modulating agents. In particular,
our data suggest a model in which cell surface xENaC activity can be
regulated by the selective insertion or removal of -xENaC.
 |
MATERIALS AND METHODS |
Cell Lines--
A6 cells were maintained in amphibian medium
containing 10% fetal bovine serum (BioWhittaker, Walkersville, MD) at
28 °C in 5% CO2. For experiments, cells were seeded at
high density on permeable supports (0.4-µm pore, Costar, Cambridge,
MA or Millipore, Bedford, MA) and used at least 8 days post-plating.
HeLa cells were maintained in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum (Atlanta Biologicals,
Norcross, GA), streptomycin (100 µg/ml), and penicillin (100 units/ml).
Antibodies and Reagents--
Generation and affinity
purification of anti - and -xENaC antibodies is described in
Rokaw et al. (8). Affinity-purified anti -xENaC antibody,
generated against a peptide encoding residues 107-125 of -xENaC,
was a generous gift of Dr. Thomas Kleyman (University of Pennsylvania
and Veterans Affairs Medical Center, Philadelphia, PA) and is described
and characterized in Zuckerman et al. (9). An anti -xENaC
antibody, generated against this region of the protein by our
laboratory, that recognizes proteins of the same molecular weights was
also used in some experiments. Insulin (humulin R) was purchased from
Eli Lilly (Indianapolis, IN), and aldosterone, vasopressin (ADH),
brefeldin A (BFA), and amiloride were from Sigma.
Expression of xENaC Subunits in HeLa Cells--
Expression of
xENaC subunits in HeLa cells was performed essentially as described in
Weisz et al. (10). HeLa cells were plated on 35-mm dishes at
approximately 40% confluence. The following day, cells were infected
at 37 °C with recombinant vaccinia virus encoding T7 RNA polymerase
(vTF7.3) at a multiplicity of infection of 10-20. After adsorption for
30 min, the inoculum was replaced with 0.75 ml of serum-free
Dulbecco's modified Eagle's medium containing 3 µg of total DNA and
5 µl of LipofectAMINE (Life Technologies, Inc.). At 3 h
post-infection, cells were starved for 15 min in cysteine-free,
methionine-free Dulbecco's modified Eagle's medium, then labeled for
2 h with 100 µCi/ml [35S]methionine (in
vitro labeling mix; PerkinElmer Life Sciences). After
rinsing with phosphate-buffered saline, cells were lysed in detergent
solution (50 mM Tris, pH 8.0, 1% Nonidet P-40, 0.4% deoxycholate, 62.5 mM EDTA, and 1 µg/ml aprotinin). After
brief centrifugation (1 min at maximal speed in a
microcentrifuge) to remove nuclei, SDS was added to a final
concentration of 0.2%. Lysates were immunoprecipitated using the
appropriate anti-xENaC antibodies, eluted, divided into two aliquots,
and mock-treated or treated with N-glycanase (New England
BioLabs, Beverly, MA). Samples were immunoprecipitated using the
appropriate anti-xENaC antibodies and electrophoresed on 10% SDS-PAGE
gels. Radiolabeled bands were visualized using phosphorimaging
with Quantity One software (Personal Molecular Imager FX; Bio-Rad).
Modulation of Amiloride-sensitive Short Circuit Current--
A6
cells were mock-treated or treated with aldosterone (1 µM
for 18 h or 3 h), ADH (100 milliunits/ml for 30 min), insulin (100 milliunits/ml for 30 min), BFA (5 µg/ml for 3 h) or
amiloride (100 µM for 18 h). Transepithelial
potential difference and short circuit current
(Isc) were measured using a sterile in-hood
short-circuiting device as described previously (11).
Half-life of ENaC Subunits--
A6 cells were starved for 30 min, then radiolabeled for 1 h and chased for 0-4 h. Individual
filters were solubilized in detergent solution, and ENaC subunits were
immunoprecipitated as described above and analyzed on SDS-PAGE gels. To
determine the half-life of ENaC subunits that had reached the apical
membrane, A6 cells grown on 6-well filter inserts were chilled and
biotinylated on ice with sulfo-NHS-SS-biotin (Pierce). Cells were
subsequently returned to 28 °C for various chase periods. At each
time point, cells were solubilized, biotinylated subunits were
recovered by binding to streptavidin-agarose, and samples were washed
and electrophoresed on SDS-PAGE gels. Two filter inserts were combined
for each time point. After transfer to nitrocellulose, gels were probed
with anti-xENaC antibodies, and the half-life of each subunit tagged at
the cell surface was quantitated by measuring the decrease in
biotinylated subunit recovered with time. For -xENaC quantitation, the intensities of the 150- and 180-kDa bands were summed; for -xENaC quantitation, both the 97-kDa band and the minor higher Mr species (when observed) were summed; and for
-xENaC quantitation, the intensity of the 95-kDa band was measured
(see Table I).
Subcellular Fractionation of Endocytic Compartments in A6
Cells--
A6 cells grown on filter inserts were treated with hormone
or diluent for the specified period of time. The cells were washed twice in Dulbecco's modified Eagle's medium, scraped into
phosphate-buffered saline, and pelleted at 15,000 × g
in a microcentrifuge. Cells were resuspended in 600 µl of HB (250 mM sucrose, 10 mM Hepes, 0.5 mM
EDTA, pH 7.4) containing protease inhibitors by passing through a
200-1000-µl pipette tip 10 times, then lysed by passing through a
22-gauge needle 20 times. The nuclei were pelleted at 600 × g, and the post-nuclear supernatant was diluted 1:1 with 62% sucrose and placed at the bottom of a 4.4-ml polyclear centrifuge tube (Seton Scientific, Sunnyvale, CA). 1.5 ml of 35% sucrose was
layered on top followed by 1.5 ml of 25% sucrose and 0.5 ml of HB. The
gradients were centrifuged in a TST 60.1 rotor at 167,000 × g for 70 min at 4 °C, and the interfaces were
collected. Protein-matched samples were run on SDS-PAGE gels,
transferred to nitrocellulose, and probed with anti-xENaC antibodies.
Quantitation of internalized horseradish peroxidase in gradient
fractions was performed using the assay described in Steinman et
al. (12).
 |
RESULTS |
Characterization of anti-xENaC Antibodies--
We previously
generated antibodies against - and -xENaC and confirmed that
these antibodies recognize proteins of the appropriate molecular mass
in A6 cells by immunoprecipitation and Western blotting (8). In
addition, we recently acquired an antibody against -xENaC from Dr.
Thomas Kleyman. By Western blotting, this antibody recognizes bands of
70, 150, and 180 kDa in A6 cells (9). The 180-kDa band likely
represents a homodimer of mature -xENaC and is preferentially
recovered from apical membrane preparations of A6 cells (9). The
identity of the 150-kDa band is unknown but appears to represent a form
of -xENaC that is primarily intracellular, as it is frequently in
lower abundance when we blot ENaC biotinylated at the apical membrane
of A6 cells. All three bands are competed away by preincubating the
antibody with immunizing peptide (9). Another group has also observed
migration of -ENaC at 150 and 180 kDa (13), and an antibody
generated in this laboratory against the carboxyl-terminal sequence of
-xENaC recognizes the 180-kDa protein (8, 9). To verify that our
antibodies react specifically with xENaC subunits, we expressed -,
-, and -xENaC from cDNA in HeLa cells using recombinant
vaccinia virus and immunoprecipitated radiolabeled cells using anti
-, -, or -xENaC antibodies (Fig. 1A). None of the antibodies
recognized proteins from mock-infected HeLa cells. Anti- -xENaC
immunoprecipitated a protein of approximately 65 and 75 kDa from HeLa
cells transfected with -xENaC (Table 1). Anti -xENaC recognized
two bands of molecular masses ~70 and 97 kDa from cells transfected
with -xENaC, and anti -xENaC recognized 2 bands of molecular
masses 75 and 95 kDa from cells transfected with -xENaC. In the case
of - and -xENaC, treatment with N-glycanase resulted
in collapse of the more slowly migrating band into the band with faster
mobility. Treatment of -xENaC immunoprecipitates with
N-glycanase caused a shift in the migration of the higher
molecular mass band; however, this band did not migrate with the lower
molecular mass band, suggesting a further post-translational
modification of this subunit. The nonglycosylated subunits that we
observed in this overexpression system have previously been observed in
other heterologous expression systems, and are not membrane associated
nor do they represent degradation intermediates (14). It is likely that
these forms are an aberration induced by overexpression. To confirm
that endogenous ENaC expressed in A6 cells was glycosylated, we
biotinylated the apical membrane of polarized cells, recovered surface
proteins using streptavidin-agarose, and treated the samples with
N-glycanase. ENaC subunits were then detected by Western
blotting (Fig. 1b). The mobilities of both - and
-xENaC shifted to 70 and 75 kDa as expected. However, neither
N-glycanase nor endoglycosidase H treatment affected the mobility of the -xENaC bands. We suspect that these high molecular mass forms of -xENaC may be aggregated or modified in such a way
that they are resistant to deglycosylation. However, another group has
reported that ENaC subunits at the cell surface of CHO cells appear to
be deglycosylated (75).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 1.
Anti-xENaC antibodies immunoprecipitate
(IP) individual xENaC subunits expressed in HeLa
cells. A, -, -, or -xENaC were expressed in HeLa
cells using the recombinant vaccinia virus T7 system as described under
"Materials and Methods." A mock-transfected sample was included as
a control for each subunit. Cells were starved, radiolabeled for 1 h, then solubilized and immunoprecipitated using anti-xENaC antibodies.
Samples were analyzed by SDS-PAGE. M, molecular mass
markers. B, anti-xENaC antibodies recognize individual xENaC
subunits biotinylated at the apical membrane of A6 cells. A6 cells were
biotinylated on ice, then solubilized and incubated with
streptavidin-agarose to recover cell surface proteins. Samples were
eluted, split in half, and mock-treated or treated with
N-glycanase. After electrophoresis under reducing
conditions, the samples were transferred to nitrocellulose and blotted
with anti-xENaC antibodies. The migration of molecular mass standards
is noted on the left.
|
|
Half-lives and Steady State Distribution of xENaC Subunits in A6
Cells--
We used these antibodies to measure the half-life of newly
synthesized xENaC subunits as well as xENaC subunits that had reached the apical plasma membrane of polarized A6 cells. Consistent with a
previously published study (15) we found that the half-life of newly
synthesized ENaC subunits is relatively short in A6 cells, with a
half-life of approximately 2 h for each subunit (Fig.
2). In addition, we measured the relative
amounts of individual ENaC subunits at the plasma membrane at steady
state. Biotinylated proteins were precipitated from 200 µg of cell
lysate using streptavidin-agarose, electrophoresed, and Western-blotted
using antibodies against the individual xENaC subunits (Fig.
3, right lane). The
signal was compared with the amount of each ENaC subunit in 40 µg of cell lysate (Fig. 3, left lane). Based on this and other
similar experiments, we estimate that that roughly 20% of each subunit is at the cell surface under steady state conditions. Importantly, this
steady state distribution of ENaC subunits is considerably higher than
that reported in oocytes (14), where less than 1% of the total
subunits were detected at the plasma membrane. This observation
suggests that there could be significant differences in the regulation
of ENaC traffic between this overexpression system and cells that
endogenously express the channel.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
Whole cell half-lives of
-, -, and
-xENaC in A6 cells. A6 cells were starved,
radiolabeled for 1 h, then chased for the indicated times. Cells
were solubilized, and individual ENaC subunits were immunoprecipitated
as described under "Materials and Methods." Half-lives were
quantitated from SDS-PAGE gels using phosphorimaging. Quantitation of
the gels shown in the inset is shown. Similar results were
obtained in at least three experiments for each subunit.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 3.
Steady state distribution of xENaC subunits
in A6 cells. Polarized A6 cells were biotinylated using a
membrane-impermeant reagent. Cells were solubilized, and 40 µg of the
lysate was loaded in the left-hand lanes. 200 µg of protein was incubated with streptavidin-agarose to recover cell
surface xENaC subunits (right lanes). After electrophoresis
and transfer to nitrocellulose, the samples were blotted to detect
-, -, or -xENaC. Approximately 20% of the total xENaC in the
cells could be biotinylated.
|
|
Because a large fraction of newly synthesized ENaC is rapidly degraded
and does not reach the cell surface, the short half-life we measured
for newly synthesized subunits does not accurately reflect the
half-life of ENaC that has reached the cell surface. Therefore, we
biotinylated the apical membrane of polarized A6 cells and measured the
rate of degradation of individual ENaC subunits over time (Fig.
4). Interestingly, all of the ENaC
subunits at the plasma membrane had considerably longer half-lives
compared with newly synthesized subunits. Surprisingly, however,
we consistently observed that the rate of degradation of cell surface
-xENaC was considerably faster (~6-h half-life) than that of -
or -xENaC, which remained relatively stable over the 24-h time
course. The long half-life of -xENaC that has reached the cell
surface has also been independently verified in Dr. Thomas Kleyman's
laboratory.2 The surprising
observation that ENaC subunits have different rates of degradation upon
reaching the cell surface suggests the possibility that
individual subunits might traffic to or from the plasma membrane
independently (non-coordinately).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Half-lives of cell surface
-, -, and
-xENaC in A6. A6 cells were rapidly chilled to
4 °C, and the apical surfaces were biotinylated as described in
under "Materials and Methods." The cells were then warmed to
28 °C for various periods and solubilized, and biotinylated proteins
were collected using streptavidin-agarose. Samples were
electrophoresed, transferred to nitrocellulose, and probed using
anti-xENaC antibodies. A representative blot for each subunit is shown.
Quantitation (mean ± S.E.) of four experiments for - and
-xENaC and three experiments for -xENaC is plotted. Statistical
significance was calculated by paired t test.
|
|
Effect of Altered Transporting Conditions on ENaC Cell Surface
Subunit Levels and Membrane Trafficking--
ENaC activity has been
reported to be up-regulated by various hormone treatments including
aldosterone, ADH, and insulin. Stimulation of ENaC channel activity by
aldosterone occurs in two phases: an initial, acute phase (within 1-3
h of stimulation), thought to involve activation of silent or inactive
channels resident in the apical membrane, and a late phase, (upon
overnight stimulation) whose mechanism is unknown. The mechanism of
action of these agents in kidney remains unclear but does not appear to
involve synthesis of new channel subunits. By contrast,
hyperpolarization with the sodium channel inhibitor amiloride appears
to decrease ENaC activity as an adaptive response (16). We therefore
tested the effects of these treatments on ENaC activity in A6 cells. As
expected, treatment with aldosterone (both short (3 h) and long (18 h)
term), ADH (30 min), and insulin (30 min) increased short circuit
current in A6 cells (Table II). By
contrast, treatment for 3 h with the fungal metabolite BFA, which
inhibits delivery of newly synthesized proteins to the plasma membrane,
decreased amiloride-sensitive current (Table II). Next, we tested
whether the same treatments affected the surface density of xENaC
subunits in the apical membrane. To do this, we incubated A6 cells with
aldosterone (3 or 18 h), ADH (30 min), insulin (30 min), or BFA (3 h), then biotinylated the apical domains of the cells. The cells were
then solubilized, and biotinylated proteins were collected with
streptavidin-agarose, electrophoresed, transferred to nitrocellulose,
and blotted with anti-xENaC antibodies (Fig.
5). The level of -xENaC recovered after these treatments was generally unaffected, although a slight (~10%) but statistically significant decrease in apical -xENaC was observed upon treatment with ADH. By contrast, the amount of
-xENaC at the apical surface was dramatically elevated in cells
treated for 18 h with aldosterone (~60% increase;
p < 0.01) or for 30 min with ADH (~20% increase;
p < 0.01). Treatment with insulin or short term
incubation with aldosterone had no effect on the density of
-xENaC at the apical membrane, whereas incubation with BFA reduced
apical -xENaC levels. These striking results were reproducibly
observed in multiple experiments, including several experiments in
which the same blots were stripped and sequentially probed with
individual anti-xENaC antibodies in random order.
View this table:
[in this window]
[in a new window]
|
Table II
Changes in short circuit current in response to various transporting
conditions
A6 cells grown on permeable supports were mock-treated with the
indicated hormones or drugs and short circuit was measured as described
under "Materials and Methods". Mean ± S.D. from at least 31 independent determinations is shown. All values were significantly
different from control (p < 0.05) by independent
t test.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 5.
Altered transport conditions modulate the
surface density of - but not
- or -xENaC. A6 cells
were mock-treated or treated with aldosterone (Aldo, 18 h or 3 h), ADH, insulin, or BFA as described under
"Materials and Methods." Cells were then rapidly chilled to
4 °C, the apical membranes were biotinylated, and the cells were
solubilized. Biotinylated proteins were collected using
streptavidin-agarose, samples were electrophoresed and transferred to
nitrocellulose, and blots were sequentially probed using anti-xENaC
subunit antibodies; representative blots for each condition are shown.
The blots on the left were sequentially probed with anti- - and
-xENaC; a blot from a separate experiment was probed with
anti- -xENaC. The blot on the right was probed sequentially with all
three anti-xENaC antibodies. Quantitation of six to nine paired
experiments (mock-treated versus experimental) for each
condition (mean ± S.E.) is shown in the lower panel.
Statistical significance was calculated from the raw data by paired
t test.
|
|
The altered cell surface distribution of -xENaC in response to short
term ADH might be due to increased delivery of newly synthesized or
recycling proteins, decreased endocytosis or degradation, or to a
combination of these effects. Internalization of ENaC expressed in
Xenopus oocytes (measured as a decrease in current density)
has been shown to occur via a dynamin-dependent mechanism, suggesting that ENaC may traffic to endosomes (17). Changes in ENaC
internalization and recycling would be expected to result in reduced
levels of -xENaC in endosomal compartments. To examine this
possibility, we isolated endosomal populations from non-stimulated or
ADH-stimulated A6 cells and measured the levels of xENaC subunits recovered in these fractions. For this purpose, we used a flotation gradient developed to isolate endosomal fractions from other polarized epithelial cell lines. To test this method, we incubated A6 cells with
the fluid phase marker horseradish peroxidase for 10 min, then
homogenized the cells and isolated endosomal fractions on a
discontinuous sucrose gradient as described under "Materials and
Methods" (Fig. 6A). Late
endosomes are concentrated at the 8.5%, 25% sucrose interface,
whereas early endosomes are found at the 25%, 35% sucrose interface,
very similar to the pattern observed using mammalian cells (18). Upon
fractionation of untreated A6 cells, we found ENaC subunits in early
endosomes but not at the interface containing late endosomes (not
shown), consistent with the presence of a recycling population of
channel subunits. In response to ADH, where apical membrane -xENaC
increased, endosomal levels of -xENaC decreased, suggesting either
an increase in exocytosis or a decrease in recycling in response to ADH
(Fig. 6, B and C). By contrast, the levels of
- and -xENaC typically increased in these endosomal fractions,
although the changes were not statistically significant compared with
mock-treated cells (Fig. 6, B and C). This
difference in the response of -xENaC to ADH was detected in multiple
experiments and was observed when the same blot was sequentially probed
with all three anti-xENaC antibodies (Fig. 6B). Thus, our
data suggest that acute stimulation with ADH results in a dramatic
redistribution of -xENaC from an endosomal pool to the apical
surface of A6 cells. Altogether, our data suggest that selective
delivery and/or retrieval of individual subunits can be regulated in a
non-coordinate manner and that a selective increase in the level of
cell surface -xENaC compared with the other ENaC subunits could
account for the increased sodium conductance observed in hormonally
stimulated cells.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 6.
Redistribution of
-xENaC from endosomes in response to ADH.
Panel A, Isolation of early and late endosomes from A6 cells
by subcellular fractionation. A6 cells were allowed to internalize
horseradish peroxidase (HRP) for 10 min at 28 °C, then
homogenized and fractionated as described under "Materials and
Methods." Individual fractions were collected and assayed for
horseradish peroxidase activity. The migration of early and late
endosomes in these gradients is noted. Panels B and
C, A6 cells were mock-treated or treated with ADH for 30 min, then fractionated as above. Early endosomal fractions were blotted
with anti xENaC antibodies. A single blot that was probed sequentially
with anti-xENaC antibodies is shown in panel B, and
quantitation of three independent experiments (mean ± S.E.) is
shown in panel C. Statistical significance was calculated by
paired analysis of the raw data; * p 0.05.
|
|
 |
DISCUSSION |
We have investigated the trafficking and turnover of endogenous
ENaC in the hormonally responsive, well characterized kidney cell line
A6. As previously observed in these and other cells (14, 15, 19), we
found that the majority of newly synthesized ENaC is rapidly degraded
shortly after synthesis. However, by contrast to results reported in
Xenopus oocytes, in which <1% of the total ENaC was
present at the plasma membrane at steady state (14), a significant
amount of total cellular ENaC subunits are present at the plasma
membrane of A6 cells at steady state. Moreover, we found that the
half-life of ENaC that reaches the plasma membrane is considerably
longer than that of newly synthesized subunits and, interestingly,
differs among subunits, with -xENaC having the shortest half-life.
Up-regulation of ENaC activity by long term treatment with aldosterone
or acute treatment with ADH, both predicted by electrophysiological
studies to increase cell surface channel number (20-23), caused a
dramatic and selective elevation in the level of -xENaC recovered at
the apical plasma membrane. Brief treatment with aldosterone or
insulin, where evidence for an increase in surface channel number is
more conjectural (22, 24, 25), had no effect on the surface levels of
any ENaC subunits. Incubation for 3 h with brefeldin A, which
prevents delivery of newly synthesized proteins to the plasma membrane, resulted in the selective reduction of -xENaC at the cell surface as well as a decrease in Isc. Our data are
consistent with a model in which changes in ENaC activity in response
to stimulation by some hormones or by alterations in sodium influx in
A6 cells is caused by selective -xENaC insertion into or retrieval
from the apical membrane. We suggest the intriguing possibility that
assembly and disassembly of ENaC channels can occur at multiple
intracellular locations and that delivery and/or retrieval of
individual subunits can be regulated in a non-coordinate fashion.
Several lines of evidence suggest that apical membrane surface
expression and stoichiometry of ENaC channels in polarized tissues and
cells is complex. First, various stoichiometries of the subunits have
been described in terms of the ultimate channel expressed in membranes.
Two groups have determined, using several approaches, that the
stoichiometry is 2 , 1 , and 1 subunit (27, 28). By contrast,
Welsh and co-workers (29-31) describe a channel made up of 9 subunits,
trimers of the three individual subunits. Interestingly, this group has
also reported that individual subunits of human ENaC, when expressed
independently, can oligomerize into homomultimers that efficiently
traffic to the cell surface (32, 33). It is known that the subunit
alone is capable of forming a channel (34) and that dimer channels of
either  or  can be expressed that demonstrate modest
differences in ion selectivity, amiloride sensitivity, and open
probability in relation to trimer channels (35). However, these
heterodimeric channels generate only a fraction (10-15%) of the
current seen when all three subunits are expressed (35); this suggests
that remodeling of surface channel subunit composition could serve as a
rapid and efficient mechanism to dramatically alter Na+
absorption at the apical membrane of cells. Generally such channels have not been observed in nature, possibly because of their low level
of activity. Nonetheless, the recent demonstration that, unlike
-ENaC-deficient mice, - and -ENaC deficient mice do not die
due to failure to clear lung liquid at birth suggests that  and
 dimers may have sufficient channel activity for pulmonary
clearance (36-40). These observations suggest that there may be
differing physiologic responses to varying expression of individual
subunits of ENaC. Moreover, an additional subunit ( -ENaC) has been
identified and may contribute to the diversity of channel stoichiometries in vivo (41).
Second, the considerable variability in expression and regulation of
ENaC subunit mRNA and protein across epithelial tissues that
express the channel may also be taken to reflect a plasticity of
channel composition in the apical membrane. In rat kidney, message for
all three subunits is expressed constitutively and changes little with
salt restriction (42). Other investigators described modest changes
primarily in subunit mRNA in rat kidney in response to steroid
stimulation or adrenalectomy (42, 43). A recent study demonstrated
significant increases in total -rENaC protein in response to
elevated aldosterone levels in rat kidney (44). However, other studies
in the same tissue found no significant effects of steroid treatment on
protein expression (42). By contrast, colon seems to express mRNA
for -xENaC constitutively, whereas - and -xENaC message are
selectively induced by mineralocorticoids (42, 43, 45). In lung tissue,
mRNA for the three subunits is primarily regulated by
glucocorticoids (42), but as in colon, non-coordinate expression of
subunits has been described (5, 46, 47). These observations suggest
that new heterotrimeric channels could be created in response to
alteration in message levels of only one or two of the subunits
in vivo.
A third line of evidence suggesting channel diversity is the
variability of single channel properties of ENaC expressed in cells and
tissues (reviewed in Ref. 1). Single channel open probability of ENaC
in A6 cells varied widely (16) (48), and within patches of channels in
cortical collecting tubules, the open probabilities resolved into two
distinct populations of channels with either high or low values (49,
50), both different from the rather high open probability seen with
trimer channels expressed in oocytes (5). The data on variability of
message expression and microscopic properties of ENaC across tissues
has led Garty and Palmer (1) and McNicholas and Canessa (35) to
speculate that there may be varying modular arrangements of channels
expressed in these membranes.
Finally, several other instances have been described in which
individual subunit combinations can associate to generate distinct heteromultimeric channels with unique functional properties. Excellent examples of this are the P2X receptor subunits, which have similar topology to ENaC subunits and that coassemble to form channels with
widely distinct properties (51-54). Other heteromultimeric channels,
such as ligand-gated receptors, cAMP-gated channels, -aminobutyric
acid receptors, and some K+ channels, can also combine to
generate different channels with unique functional properties (55-61).
In addition, in the case of gap junction assembly, it is clear that
heteromeric channels composed of different connexin subunits can form
and that at least some connexin subunits can assemble into ion channels
after exiting the endoplasmic reticulum (62, 63). Thus, although our
suggestion that ENaC subunits can recombine into multiple heteromeric
channels possibly at or near the apical membrane runs contrary to the
generally accepted notion that all heteromeric channels combine with
fixed stiochiometry in the endophasmic reticulum, some evidence for this paradigm already exists.
Our data also suggest the possibility that ENaC channels of differing
stoichiometry may normally exist at the cell surface. This hypothesis
in no way alters the likelihood that a channel containing all three
subunits is the entity mainly responsible for Na+
reabsorption. Most of these partial channels would be physiologically unimportant in most circumstances due to their low level of activity. However, if channels can assemble as some site beyond the endophasmic reticulum, then insertion into or retrieval from the apical membrane of
individual ENaC subunits could contribute to the rapid modulation of
surface ENaC activity in response to extracellular Na+
changes or hormonal stimuli and could represent one mechanism of
activation of "electrically silent" channels resident in the apical
membrane. The strongest evidence against this hypothesis comes from the
studies of Firsov et al. (64), which demonstrate that
variability in expression of one subunit in oocytes does not change the
apparent heterotrimeric structure at the oocyte membrane. However, ENaC
assembly may be differentially regulated in this overexpression system
compared with its assembly in polarized epithelial tissues that
endogenously express the channel. Even in endogenously expressing
epithelia, normal trafficking of ENaC depends on establishment of the
complete epithelial phenotype. For example, there is a marked
difference between ENaC activity in A6 cells grown on glass as opposed
to permeable supports that allow exposure to media on both sides of the
cell (65).
It is interesting to compare our direct measures of apical membrane
ENaC subunits with the predictions made by other techniques concerning
channel density under varying conditions of transport. We found that
both ADH and long term aldosterone increased apical membrane -xENaC.
In both of these conditions, estimates of channel activity by
electrophysiologic techniques or biochemical methods suggest an
increase in the number of active apical membrane holochannels (20, 21,
67, 68, 73). This suggests that -xENaC delivered from intracellular
compartments may assemble with  heterodimers already present at
the cell surface. The observation that mice deficient in - or
-ENaC can clear lung liquid at birth suggests that  and 
dimers may form in vivo as well (36, 38-40). In contrast to
the ADH and long term aldosterone effect, both short term aldosterone
and insulin resulted in no detectable change in apical membrane xENaC
subunits. This is consistent with patch-clamp estimates of a primary
effect on channel kinetics rather than number under these conditions
(1, 24, 72) as well as with biochemical estimates of channel number
with short term aldosterone. On the other hand, studies using noise
analysis suggest that both insulin and short term aldosterone markedly
increase channel density (22, 23). It is possible that this represents
a qualitative rather than a quantitative difference, since channels
with very low open probability that increased following hormonal
stimulation could appear as new channels using this approach (49, 50). With regard to the BFA experiments, our finding of a selective decrease
in apical membrane -ENaC subunit levels is consistent with the
observation that this subunit has the shortest half-life in untreated
cells; this would be expected to appear as a decrease in apical channel
density as measured by noise analysis (74).
An alternative explanation for our data is that the increase in cell
surface -xENaC does not directly contribute to aldosterone- or
ADH-stimulated current. It is possible that the biotinylation efficiency of ENaC subunits in fully active versus partially
assembled channels could be dramatically different, and this could lead to incorrect estimates of turnover rates for each subunit. We feel that
this is unlikely because we can efficiently biotinylate a large
fraction of each ENaC subunit in A6 cells (approximately 20% of the
total at steady state, Fig. 2) and because there are numerous lysine
residues on the extracellular domain of all three subunits (at least 12 per subunit). Moreover, the changes we measured in cell surface
-xENaC upon physiologic manipulation mirrored the changes in
Isc in all cases. In addition, the selective
decrease in cell surface -xENaC in BFA-treated cells is consistent
with the comparatively short cell surface half-life that we measured for this subunit in untreated cells. Finally, although noise analysis predicts a 2-3-fold increase in channel number in response to ADH and
long term aldosterone treatment, it is unlikely that we would have
missed a change of this magnitude in all subunits. Importantly,
insertion of even a few -ENaC subunits into the membrane could cause
a significantly greater proportional increase in channel activity
because the activity of  heterodimeric channels is only 15-20%
that of the holochannel (35). Thus we feel that the most parsimonious
explanation for our results is that ENaC channel stoichiometry is dynamic.
In summary, our data suggest that in contrast to newly synthesized
subunits, ENaC subunits reaching the plasma membrane of A6 cells are
normally long-lived. Furthermore, ENaC subunits appear to be
differentially inserted into or retrieved from the cell surface both
under steady state conditions and in response to physiologic
modulation. Our data are consistent with a model in which changes in
ENaC activity in response to stimulation by some hormones or by
alterations in sodium influx is caused by selective -xENaC insertion
into or retrieval from the apical membrane. However, more studies are
clearly necessary to understand the mechanism behind this selective
trafficking, as well as its contribution to regulation of ENaC in
different species and tissues.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Thomas Kleyman for his gift of
anti -xENaC antibody and for communicating results before
publication and Jennifer Henkel, Gregory Gibson, Daniel Hui, and Bing
An for expert and cheerful technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants R01DK47874 (to J. P. J.) and R01DK54407 (to O. A. W.) and by
a grant from the Cystic Fibrosis Foundation (to O. A. W.). The
Laboratory of Epithelial Cell Biology is supported in part by Dialysis
Clinic Inc.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Renal-Electrolyte
Division, University of Pittsburgh, 3550 Terrace St., Pittsburgh, PA
15261. Tel.: 412-648-9075; Fax: 412-383-8956; E-mail:
johnson@msx.dept-med.pitt.edu.
Published, JBC Papers in Press, September 7, 2000, DOI 10.1074/jbc.M003822200
2
T. Kleyman, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
ENaC, epithelial
sodium channel;
xENaC, Xenopus ENaC;
ADH, vasopressin;
BFA, brefeldin A;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Garty, H.,
and Palmer, L. G.
(1997)
Physiol. Rev.
77,
359-396
|
| 2.
|
Shimkets, R. A.,
Warnock, D. G.,
Bositis, C. M.,
Nelson-Williams, C.,
Hansson, J. H.,
Schambelan, M.,
Gill, J. R., Jr.,
Ulick, S.,
Milora, R. V.,
Findling, J. W.,
et al..
(1994)
Cell
79,
407-414
|
| 3.
|
Chang, S. S.,
Grunder, S.,
Hanukoglu, A.,
Rosler, A.,
Mathew, P. M.,
Hanukoglu, I.,
Schild, L.,
Lu, Y.,
Shimkets, R. A.,
Nelson-Williams, C.,
Rossier, B. C.,
and Lifton, R. P.
(1996)
Nat. Genet.
13,
248-250
|
| 4.
|
Boucher, R. C.,
Stutts, M. J.,
Knowles, M. R.,
Cantley, L. C.,
and Gatzy, J. T.
(1986)
J. Clin. Invest.
78,
1245-1252
|
| 5.
|
Burch, L. H.,
Talbot, C. R.,
Knowles, M. R.,
Canessa, C. M.,
Rossier, B. C.,
and Boucher, R. C.
(1995)
Am. J. Physiol.
269,
C511-C518
|
| 6.
|
Puoti, A.,
May, A.,
Canessa, C. M.,
Horisberger, J.-D.,
Schild, L.,
and Rossier, B. C.
(1995)
Am. J. Physiol.
269,
C188-C197
|
| 7.
|
Alvarez de la Rosa, D.,
Zhang, P.,
Naray-Fejes-Toth, A.,
Fejes-Toth, G.,
and Canessa, C. M.
(1999)
J. Biol. Chem.
274,
37834-37839
|
| 8.
|
Rokaw, M. D.,
Wang, J.-M.,
Edinger, R. S.,
Weisz, O. A.,
Hui, D.,
Middleton, P.,
Shlyonsky, V.,
Berdiev, B. K.,
Ismailov, I. I.,
Eaton, D. C.,
Benos, D. J.,
and Johnson, J. P.
(1998)
J. Biol. Chem.
273,
28746-28751
|
| 9.
|
Zuckerman, J. B.,
Chen, X.,
Jacobs, J. D.,
Hu, B.,
Kleyman, T. R.,
and Smith, P. R.
(1999)
J. Biol. Chem.
274,
23286-23295
|
| 10.
|
Weisz, O. A.,
Swift, A. M.,
and Machamer, C. E.
(1993)
J. Cell Biol.
122,
1185-1196
|
| 11.
|
Steele, R. G.,
Handler, J. S.,
Preston, A. S.,
and Johnson, J. P.
(1986)
Am. J. Physiol.
251,
C186-C190
|
| 12.
|
Steinman, R. M.,
Brodie, S. E.,
and Cohn, Y. A.
(1976)
J. Cell Biol.
68,
665-687
|
| 13.
|
Ismailov, I. I.,
Awayda, M. S.,
Berdiev, B. K.,
Bubien, J. K.,
Lucas, J. E.,
Fuller, C. M.,
and Benos, D. J.
(1996)
J. Biol. Chem.
271,
807-816
|
| 14.
|
Valentijn, J. A.,
Fyfe, G. K.,
and Canessa, C. M.
(1998)
J. Biol. Chem.
273,
30344-30351
|
| 15.
|
May, A.,
Puoti, A.,
Gaeggeler, H.-P.,
Horisberger, J.-D.,
and Rossier, B. C.
(1997)
J. Am. Soc. Nephrol.
8,
1813-1822
|
| 16.
|
Ling, B. N.,
and Eaton, D. C.
(1989)
Am. J. Physiol.
256,
F1094-F1103
|
| 17.
|
Shimkets, R. A.,
Lifton, R. P.,
and Canessa, C. M.
(1997)
J. Biol. Chem.
272,
25537-25541
|
| 18.
|
Leung, S.-M.,
Ruiz, W. G.,
and Apodaca, G.
(2000)
Mol. Biol. Cell
6,
2131-2150
|
| 19.
|
Staub, O.,
Gautschi, I.,
Ishikawa, T.,
Breitschopf, K.,
Ciechanover, A.,
Schild, L.,
and Rotin, D.
(1997)
EMBO J.
16,
6325-6336
|
| 20.
|
Marunaka, Y.,
and Eaton, D. C.
(1991)
Am. J. Physiol.
260,
C1071-C1084
|
| 21.
|
Pacha, J.,
Frindt, G.,
Antonian, L.,
Silver, R. B.,
and Palmer, L. G.
(1993)
J. Gen. Physiol.
102,
25-42
|
| 22.
|
Blazer-Yost, B. L.,
Liu, X.,
and Helman, S. I.
(1998)
Am. J. Physiol.
274,
C1373-C1379
|
| 23.
|
Helman, S. I.,
Cox, T. C.,
and van Driessche, W.
(1983)
J. Gen. Physiol.
82,
201-220
|
| 24.
|
Marunaka, Y.,
Hagiwara, N.,
and Tohda, H.
(1992)
Am. J. Physiol.
263,
F392-F400
|
| 25.
|
Erlij, D.,
De Smet, P.,
and van Driessche, W.
(1994)
J. Physiol.
481,
553-542
|
| 26.
|
Rokaw, M. D.,
Sarac, E.,
Lechman, E.,
West, M.,
Angeski, J.,
Johnson, J. P.,
and Zeidel, M. L.
(1996)
Am. J. Physiol.
270,
C600-C607
|
| 27.
|
Firsov, D.,
Gautschi, I.,
Merillat, A.-M.,
Rossier, B. C.,
and Schild, L.
(1998)
EMBO J.
17,
344-352
|
| 28.
|
Kosari, F.,
Sheng, S.,
Li, J.,
Mak, D-O. D.,
Foskett, J. K.,
and Kleyman, T. R.
(1998)
J. Biol. Chem.
273,
13469-13474
|
| 29.
|
Cheng, C.,
Prince, L. S.,
Snyder, P. A.,
and Welsh, M. J.
(1998)
J. Biol. Chem.
273,
22693-22700
|
| 30.
|
Eskandari, S.,
Snyder, P. M.,
Kreman, M.,
Zampighi, G. A.,
Welsh, M. J.,
and Wright, E. M.
(1999)
J. Biol. Chem.
274,
27281-27286
|
| 31.
|
Snyder, P. A.,
Cheng, C.,
Prince, L. S.,
Rogers, J. C.,
and Welsh, M. J.
(1997)
J. Biol. Chem.
273,
681-684
|
| 32.
|
Adams, C. M.,
Snyder, P. A.,
and Welsh, M. J.
(1997)
J. Biol. Chem.
272,
27295-27300
|
| 33.
|
Prince, L. S.,
and Welsh, M. J.
(1998)
Biochem. J.
336,
705-710
|
| 34.
|
Canessa, C. M.,
Horisberger, J.-D.,
and Rossier, B. C.
(1993)
Nature
361,
463-467
|
| 35.
|
McNicholas, C. M.,
and Canessa, C. M.
(1997)
J. Gen. Physiol.
109,
681-692
|
| 36.
|
Hummler, E.,
and Horisberger, J.-D.
(1999)
Am. J. Physiol.
276,
G567-G571
|
| 37.
|
Pradervand, S.,
Barker, P. M.,
Wang, Q.,
Ernst, S. A.,
Beermann, F.,
Grubb, B. R.,
Burnier, M.,
Schmidt, A.,
Bindels, R. J. M.,
Gatzy, J. T.,
Rossier, B. C.,
and Hummler, E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1732-1737
|
| 38.
|
Hummler, E.,
Barker, P.,
Gatzy, J.,
Beermann, F.,
Verdumo, C.,
Schmidt, A.,
Boucher, R.,
and Rossier, B. C.
(1996)
Nat. Genet.
12,
325-328
|
| 39.
|
Barker, P. M.,
Nguyen, M. S.,
Gatzy, J. T.,
Grubb, B.,
Norman, H.,
Hummler, E.,
Rossier, B.,
Boucher, R. C.,
and Koller, B.
(1998)
J. Clin. Invest.
102,
1634-1640
|
| 40.
|
Schaedel, C.,
Marthinsen, L.,
Kristofferson, A.-C.,
Kornfalt, R.,
Nilsson, K. O.,
Orlenius, B.,
and Holmberg, L.
(1999)
J. Pediatr.
135,
739-745
|
| 41.
|
Waldmann, R.,
Champigny, G.,
Bassilana, F.,
Voilley, N.,
and Lazdunski, M.
(1995)
J. Biol. Chem.
270,
27411-27414
|
| 42.
|
Renard, S.,
Voilley, N.,
Bassilana, F.,
Lazdunski, M.,
and Barbry, P.
(1995)
Pfluegers Arch. Eur. J. Physiol.
430,
299-307
|
| 43.
|
Asher, C.,
Wald, H.,
Rossier, B. C.,
and Garty, H.
(1996)
Am. J. Physiol.
271,
C605-C611
|
| 44.
|
Masilamani, S.,
Kim, G.-H.,
Mitchell, C.,
Wade, J. B.,
and Knepper, M. A.
(1999)
J. Clin. Invest.
104,
R19-R23
|
| 45.
|
Escoubet, B.,
Coureau, C.,
Bonvalet, J.-P.,
and Farman, N.
(1997)
Am. J. Physiol.
272,
C1482-C1491
|
| 46.
|
Farman, N.,
Talbot, C. R.,
Boucher, R.,
Fay, M.,
Canessa, C.,
Rossier, B. C.,
and Bonvalet, J.-P.
(1997)
Am. J. Physiol.
272,
C131-C141
|
| 47.
|
Tchepichev, S.,
Ueda, J.,
Canessa, C.,
Rossier, B. C.,
and O'Brodovich, H.
(1995)
Am. J. Physiol.
269,
C805-C812
|
| 48.
|
Matsumoto, P. S.,
Ohara, A.,
Duchatelle, P.,
and Eaton, D. C.
(1993)
Am. J. Physiol.
264,
C246-C250
|
| 49.
|
Palmer, L. G.,
and Frindt, G.
(1988)
J. Gen. Physiol.
92,
121-138
|
| 50.
|
Palmer, L. G.,
and Frindt, G.
(1996)
J. Gen. Physiol.
107,
35-45
|
| 51.
|
Le, K.-T.,
Babinski, K.,
and Seguela, P.
(1998)
J. Neurosci.
18,
7152-7159
|
| 52.
|
Torres, G. E.,
Haines, W. R.,
Egan, T. M.,
and Voigt, M. M.
(1998)
Mol. Pharmacol.
54,
989-993
|
| 53.
|
Le, K.-T.,
Boue-Grabot, E.,
Archambault, V.,
and Seguela, P.
(1999)
J. Biol. Chem.
274,
15415-15419
|
| 54.
|
Torres, G. E.,
Egan, T. M.,
and Voigt, M. M.
(1999)
J. Biol. Chem.
274,
6653-6659
|
| 55.
|
Ruknudin, A.,
Shulze, D. H.,
Sullivan, S. K.,
Lederer, W. J.,
and Welling, P. A.
(1998)
J. Biol. Chem.
273,
14165-14171
|
| 56.
|
Bradley, J.,
Davidson, N.,
Lester, H. A.,
and Zinn, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
91,
8890-8894
|
| 57.
|
Chen, T. Y.,
Peng, Y. W.,
Dahallan, R. S.,
Ahamed, B.,
Reed, R. R.,
and Yau, K. W.
(1993)
Nature
362,
764-767
|
| 58.
|
Isacoff, E.,
Jan, Y. N.,
and Jan, L. Y.
(1990)
Nature
345,
530-534
|
| 59.
|
Krapivinsky, G.,
Gordon, E. A.,
Wickman, K.,
Velimiriovic, B.,
Krapivinsky, L.,
and Clapham, D. E.
(1995)
Nature
374,
135-141
|
| 60.
|
Nakanishi, N.,
Schneider, N. A.,
and Axel, R.
(1990)
Neuron
5,
569-581
|
| 61.
|
Barnard, E. A.,
Skolnick, P.,
Olsen, R. W.,
Mohler, H.,
Sieghart, W.,
Biggio, G.,
Braestrup, C.,
Bateson, A.,
and Langer, S. Z.
(1998)
Pharmacol. Rev.
50,
291-313
|
| 62.
|
Yeager, M.,
Unger, V. M.,
and Falk, M. M.
(1998)
Curr. Opin. Struct. Biol.
8,
517-524
|
| 63.
|
Musil, L. S.,
and Goodenough, D. A.
(1993)
Cell
24,
1065-1077
|
| 64.
|
Firsov, D.,
Schild, L.,
Gautschi, I.,
Merillat, A.-M.,
Schneeberger, E.,
and Rossier, B. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15370-15375
|
| 65.
|
Sariban-Sohraby, S.,
Burg, M. B.,
and Turner, R. J.
(1983)
Am. J. Physiol.
245,
C167-C171
|
| 66.
| Deleted in proof
|
| 67.
|
Palmer, L. G.,
and Lorenzen, M.
(1983)
Am. J. Physiol.
244,
F195-F204
|
| 68.
|
Kleyman, T. R.,
Ernst, S. A.,
and Coupaye-Gerard, B.
(1994)
Am. J. Physiol.
266,
F506-F511
|
| 69.
| Deleted in proof
|
| 70.
| Deleted in proof
|
| 71.
| Deleted in proof
|
| 72.
|
Kemendy, A. E.,
Kleyman, T. R.,
and Eaton, D. C.
(1992)
Am. J. Physiol.
263,
C825-C837
|
| 73.
|
Helman, S. I.,
Liu, X.,
Baldwin, K.,
Blazer-Yost, B. L.,
and Els, W. J.
(1998)
Am. J. Physiol.
274,
C947-C957
|
| 74.
|
Fisher, R. S.,
Grillo, F. G.,
and Sariban-Sohraby, S.
(1996)
Am. J. Physiol.
270,
C138-C147
|
| 75.
|
Prince, L. S.,
and Welsh, M. J.
(1998)
Biochem. J.
336,
705-710
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Vasquez, S. B. Mustafa, A. Choudary, S. R. Seidner, and R. Castro
Regulation of Epithelial Na+ Channel (ENaC) in the Salivary Cell Line SMG-C6
Experimental Biology and Medicine,
May 1, 2009;
234(5):
522 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Butterworth, R. S. Edinger, R. A. Frizzell, and J. P. Johnson
Regulation of the epithelial sodium channel by membrane trafficking
Am J Physiol Renal Physiol,
January 1, 2009;
296(1):
F10 - F24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Butterworth, O. A. Weisz, and J. P. Johnson
Some Assembly Required: Putting the Epithelial Sodium Channel Together
J. Biol. Chem.,
December 19, 2008;
283(51):
35305 - 35309.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yu, M. N. Helms, Q. Yue, and D. C. Eaton
Single-channel analysis of functional epithelial sodium channel (ENaC) stability at the apical membrane of A6 distal kidney cells
Am J Physiol Renal Physiol,
November 1, 2008;
295(5):
F1519 - F1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bhalla and K. R. Hallows
Mechanisms of ENaC Regulation and Clinical Implications
J. Am. Soc. Nephrol.,
October 1, 2008;
19(10):
1845 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Adebamiro, Y. Cheng, U. S. Rao, H. Danahay, and R. J. Bridges
A Segment of {gamma} ENaC Mediates Elastase Activation of Na+ Transport
J. Gen. Physiol.,
November 26, 2007;
130(6):
611 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pruliere-Escabasse, C. Planes, E. Escudier, P. Fanen, A. Coste, and C. Clerici
Modulation of Epithelial Sodium Channel Trafficking and Function by Sodium 4-Phenylbutyrate in Human Nasal Epithelial Cells
J. Biol. Chem.,
November 23, 2007;
282(47):
34048 - 34057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Mueller, O. B. Kashlan, J. B. Bruns, A. B. Maarouf, M. Aridor, T. R. Kleyman, and R. P. Hughey
Epithelial Sodium Channel Exit from the Endoplasmic Reticulum Is Regulated by a Signal within the Carboxyl Cytoplasmic Domain of the {alpha} Subunit
J. Biol. Chem.,
November 16, 2007;
282(46):
33475 - 33483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Hughey and T. R. Kleyman
Functional cross talk between ENaC and pendrin
Am J Physiol Renal Physiol,
November 1, 2007;
293(5):
F1439 - F1440.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tiwari, S. Riazi, and C. A. Ecelbarger
Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes
Am J Physiol Renal Physiol,
October 1, 2007;
293(4):
F974 - F984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. B. Kashlan, G. M. Mueller, M. Z. Qamar, P. A. Poland, A. Ahner, R. C. Rubenstein, R. P. Hughey, J. L. Brodsky, and T. R. Kleyman
Small Heat Shock Protein {alpha}A-crystallin Regulates Epithelial Sodium Channel Expression
J. Biol. Chem.,
September 21, 2007;
282(38):
28149 - 28156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tiwari, L. Nordquist, V. K. M. Halagappa, and C. A. Ecelbarger
Trafficking of ENaC subunits in response to acute insulin in mouse kidney
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F178 - F185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Numata, T. Shimizu, and Y. Okada
TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C460 - C467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mazzochi, D. J. Benos, and P. R. Smith
Interaction of epithelial ion channels with the actin-based cytoskeleton
Am J Physiol Renal Physiol,
December 1, 2006;
291(6):
F1113 - F1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ergonul, G. Frindt, and L. G. Palmer
Regulation of maturation and processing of ENaC subunits in the rat kidney
Am J Physiol Renal Physiol,
September 1, 2006;
291(3):
F683 - F693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anantharam, Y. Tian, and L. G. Palmer
Open probability of the epithelial sodium channel is regulated by intracellular sodium
J. Physiol.,
July 15, 2006;
574(2):
333 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Malik, S. R. Price, W. E. Mitch, Q. Yue, and D. C. Eaton
Regulation of epithelial sodium channels by the ubiquitin-proteasome proteolytic pathway
Am J Physiol Renal Physiol,
June 1, 2006;
290(6):
F1285 - F1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, L. M. Traub, K. M. Weixel, M. J. Hawryluk, N. Shah, R. S. Edinger, C. J. Perry, L. Kester, M. B. Butterworth, K. W. Peters, et al.
Clathrin-mediated Endocytosis of the Epithelial Sodium Channel: ROLE OF EPSIN
J. Biol. Chem.,
May 19, 2006;
281(20):
14129 - 14135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein
Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels
PNAS,
April 11, 2006;
103(15):
5817 - 5822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mazzochi, J. K. Bubien, P. R. Smith, and D. J. Benos
The Carboxyl Terminus of the {alpha}-Subunit of the Amiloride-sensitive Epithelial Sodium Channel Binds to F-actin
J. Biol. Chem.,
March 10, 2006;
281(10):
6528 - 6538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Woollhead and D. L. Baines
Forskolin-induced Cell Shrinkage and Apical Translocation of Functional Enhanced Green Fluorescent Protein-Human {alpha}ENaC in H441 Lung Epithelial Cell Monolayers
J. Biol. Chem.,
February 24, 2006;
281(8):
5158 - 5168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Snyder
Minireview: Regulation of Epithelial Na+ Channel Trafficking
Endocrinology,
December 1, 2005;
146(12):
5079 - 5085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-P. Ma and D. C. Eaton
Acute Regulation of Epithelial Sodium Channel by Anionic Phospholipids
J. Am. Soc. Nephrol.,
November 1, 2005;
16(11):
3182 - 3187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Butterworth, R. A. Frizzell, J. P. Johnson, K. W. Peters, and R. S. Edinger
PKA-dependent ENaC trafficking requires the SNARE-binding protein complexin
Am J Physiol Renal Physiol,
November 1, 2005;
289(5):
F969 - F977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Adebamiro, Y. Cheng, J. P. Johnson, and R. J. Bridges
Endogenous Protease Activation of ENaC: Effect of Serine Protease Inhibition on ENaC Single Channel Properties
J. Gen. Physiol.,
September 26, 2005;
126(4):
339 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Malik, Q. Yue, G. Yue, X. J. Chen, S. R. Price, W. E. Mitch, and D. C. Eaton
Role of Nedd4-2 and polyubiquitination in epithelial sodium channel degradation in untransfected renal A6 cells expressing endogenous ENaC subunits
Am J Physiol Renal Physiol,
July 1, 2005;
289(1):
F107 - F116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Volk, R. F. Husted, R. D. Sigmund, and J. B. Stokes
Overexpression of the Epithelial Na+ Channel {gamma} Subunit in Collecting Duct Cells: INTERACTIONS OF LIDDLE'S MUTATIONS AND STEROIDS ON EXPRESSION AND FUNCTION
J. Biol. Chem.,
May 6, 2005;
280(18):
18348 - 18354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Butterworth, R. S. Edinger, J. P. Johnson, and R. A. Frizzell
Acute ENaC Stimulation by cAMP in a Kidney Cell Line is Mediated by Exocytic Insertion from a Recycling Channel Pool
J. Gen. Physiol.,
December 28, 2004;
125(1):
81 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Hughey, J. B. Bruns, C. L. Kinlough, and T. R. Kleyman
Distinct Pools of Epithelial Sodium Channels Are Expressed at the Plasma Membrane
J. Biol. Chem.,
November 19, 2004;
279(47):
48491 - 48494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. de la Rosa, T. G. Paunescu, W. J. Els, S. I. Helman, and C. M. Canessa
Mechanisms of Regulation of Epithelial Sodium Channel by SGK1 in A6 Cells
J. Gen. Physiol.,
September 27, 2004;
124(4):
395 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Thomas, R. W. Loftus, and K. Z. Liu
AVP-induced VIT32 gene expression in collecting duct cells occurs via trans-activation of a CRE in the 5'-flanking region of the VIT32 gene
Am J Physiol Renal Physiol,
September 1, 2004;
287(3):
F460 - F468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Awayda, A. Bengrine, N. A. Tobey, J. D. Stockand, and R. C. Orlando
Nonselective cation transport in native esophageal epithelia
Am J Physiol Cell Physiol,
August 1, 2004;
287(2):
C395 - C402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mohan, J. R. Bruns, K. M. Weixel, R. S. Edinger, J. B. Bruns, T. R. Kleyman, J. P. Johnson, and O. A. Weisz
Differential Current Decay Profiles of Epithelial Sodium Channel Subunit Combinations in Polarized Renal Epithelial Cells
J. Biol. Chem.,
July 30, 2004;
279(31):
32071 - 32078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Staruschenko, J. L. Medina, P. Patel, M. S. Shapiro, R. E. Booth, and J. D. Stockand
Fluorescence Resonance Energy Transfer Analysis of Subunit Stoichiometry of the Epithelial Na+ Channel
J. Biol. Chem.,
June 25, 2004;
279(26):
27729 - 27734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Varga, A. Jurkuvenaite, J. Wakefield, J. S. Hong, J. S. Guimbellot, C. J. Venglarik, A. Niraj, M. Mazur, E. J. Sorscher, J. F. Collawn, et al.
Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines
J. Biol. Chem.,
May 21, 2004;
279(21):
22578 - 22584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dagenais, R. Frechette, Y. Yamagata, T. Yamagata, J.-F. Carmel, M.-E. Clermont, E. Brochiero, C. Masse, and Y. Berthiaume
Downregulation of ENaC activity and expression by TNF-{alpha} in alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol,
February 1, 2004;
286(2):
L301 - L311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Mustafa, R. J. DiGeronimo, J. A. Petershack, J. L. Alcorn, and S. R. Seidner
Postnatal glucocorticoids induce {alpha}-ENaC formation and regulate glucocorticoid receptors in the preterm rabbit lung
Am J Physiol Lung Cell Mol Physiol,
January 1, 2004;
286(1):
L73 - L80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. Weisz and J. P. Johnson
Noncoordinate regulation of ENaC: paradigm lost?
Am J Physiol Renal Physiol,
November 1, 2003;
285(5):
F833 - F842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Bruns, B. Hu, Y. J. Ahn, S. Sheng, R. P. Hughey, and T. R. Kleyman
Multiple epithelial Na+ channel domains participate in subunit assembly
Am J Physiol Renal Physiol,
October 1, 2003;
285(4):
F600 - F609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Hughey, G. M. Mueller, J. B. Bruns, C. L. Kinlough, P. A. Poland, K. L. Harkleroad, M. D. Carattino, and T. R. Kleyman
Maturation of the Epithelial Na+ Channel Involves Proteolytic Processing of the {alpha}- and {gamma}-Subunits
J. Biol. Chem.,
September 26, 2003;
278(39):
37073 - 37082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lebowitz, B. An, R. S. Edinger, M. L. Zeidel, and J. P. Johnson
Effect of altered Na+ entry on expression of apical and basolateral transport proteins in A6 epithelia
Am J Physiol Renal Physiol,
September 1, 2003;
285(3):
F524 - F531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Booth and J. D. Stockand
Targeted degradation of ENaC in response to PKC activation of the ERK1/2 cascade
Am J Physiol Renal Physiol,
May 1, 2003;
284(5):
F938 - F947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Beutler, S. Masilamani, S. Turban, J. Nielsen, H. L. Brooks, S. Ageloff, R. A. Fenton, R. K. Packer, and M. A. Knepper
Long-Term Regulation of ENaC Expression in Kidney by Angiotensin II
Hypertension,
May 1, 2003;
41(5):
1143 - 1150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rohatgi, A. Greenberg, C. R. Burrow, P. D. Wilson, and L. M. Satlin
Na Transport in Autosomal Recessive Polycystic Kidney Disease (ARPKD) Cyst Lining Epithelial Cells
J. Am. Soc. Nephrol.,
April 1, 2003;
14(4):
827 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Na, Y. K. Oh, J. S. Han, K. W. Joo, J. S. Lee, J.-H. Earm, M. A. Knepper, and G.-H. Kim
Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats
Am J Physiol Renal Physiol,
January 1, 2003;
284(1):
F133 - F143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Planes, M. Blot-Chabaud, M. A. Matthay, S. Couette, T. Uchida, and C. Clerici
Hypoxia and beta 2-Agonists Regulate Cell Surface Expression of the Epithelial Sodium Channel in Native Alveolar Epithelial Cells
J. Biol. Chem.,
November 27, 2002;
277(49):
47318 - 47324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Hill, B. An, and J. P. Johnson
Endogenously Expressed Epithelial Sodium Channel Is Present in Lipid Rafts in A6 Cells
J. Biol. Chem.,
September 6, 2002;
277(37):
33541 - 33544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, K. W. Peters, F. Sun, C. R. Marino, J. Lang, R. D. Burgoyne, and R. A. Frizzell
Cysteine String Protein Interacts with and Modulates the Maturation of the Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem.,
August 2, 2002;
277(32):
28948 - 28958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Morris and J. A. Schafer
cAMP Increases Density of ENaC Subunits in the Apical Membrane of MDCK Cells in Direct Proportion to Amiloride-sensitive Na+ Transport
J. Gen. Physiol.,
June 24, 2002;
120(1):
71 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. de la Rosa, H. Li, and C. M. Canessa
Effects of Aldosterone on Biosynthesis, Traffic, and Functional Expression of Epithelial Sodium Channels in A6 Cells
J. Gen. Physiol.,
April 15, 2002;
119(5):
427 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Snyder
The Epithelial Na+ Channel: Cell Surface Insertion and Retrieval in Na+ Homeostasis and Hypertension
Endocr. Rev.,
April 1, 2002;
23(2):
258 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Stockand
New ideas about aldosterone signaling in epithelia
Am J Physiol Renal Physiol,
April 1, 2002;
282(4):
F559 - F576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, K. S. Hering-Smith, F. R. Schiro, and L. L. Hamm
Serine Protease Activity in M-1 Cortical Collecting Duct Cells
Hypertension,
April 1, 2002;
39(4):
860 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hanwell, T. Ishikawa, R. Saleki, and D. Rotin
Trafficking and Cell Surface Stability of the Epithelial Na+ Channel Expressed in Epithelial Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
9772 - 9779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rotin, V. Kanelis, and L. Schild
Trafficking and cell surface stability of ENaC
Am J Physiol Renal Physiol,
September 1, 2001;
281(3):
F391 - F399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Kleyman, J. B. Zuckerman, P. Middleton, K. A. McNulty, B. Hu, X. Su, B. An, D. C. Eaton, and P. R. Smith
Cell surface expression and turnover of the alpha -subunit of the epithelial sodium channel
Am J Physiol Renal Physiol,
August 1, 2001;
281(2):
F213 - F221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hanwell, T. Ishikawa, R. Saleki, and D. Rotin
Trafficking and Cell Surface Stability of the Epithelial Na+ Channel Expressed in Epithelial Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
9772 - 9779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. de la Rosa, H. Li, and C. M. Canessa
Effects of Aldosterone on Biosynthesis, Traffic, and Functional Expression of Epithelial Sodium Channels in A6 Cells
J. Gen. Physiol.,
April 15, 2002;
119(5):
427 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|